Inventor · disambiguated record
Tugrul Kararli
Also filed as: KARARLI TUGRUL T
7 granted patents·10 pending applications·305 citations·filing 1991–2007
88Inventor score
Top patents by PatentIndex Score
17 records- 0183US5213807APharmaceutical composition containing ibuprofen and a prostaglandinCHEMBURKAR PRAMOD B·Filed 1991·Granted May 25, 1993·108 cites·14 claims
- 0282US6964978B2Solid-state form of celecoxib having enhanced bioavailabilityPHARMACIA CORP·Filed 2000·Granted Nov 15, 2005·22 cites·4 claims
- 0382US5230897ATransdermal pentamidineSEARLE & CO·Filed 1991·Granted Jul 27, 1993·105 cites·30 claims
- 0480US7172769B2Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effectPHARMACIA CORP·Filed 2000·Granted Feb 6, 2007·13 cites·17 claims
- 0578US7220867B2Solid-state form of celecoxib having enhanced bioavailabilityPHARMACIA CORP OF PFIZER INC·Filed 2005·Granted May 22, 2007·5 cites·6 claims
- 0673US7695736B2Reconstitutable parenteral compositionPFIZER·Filed 2002·Granted Apr 13, 2010·8 cites·34 claims
- 0771US5935939AStabilized dispersions of misoprostolSEARLE & CO·Filed 1996·Granted Aug 10, 1999·44 cites·9 claims
- 0853US2007202160A1Solid-state form of celecoxib having enhanced bioavailabilityPHARMACIA CORP·Filed 2007·Application pending·0 cites
- 0948US2002142045A1Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effectFiled 2002·Application pending·0 cites
- 1046US2003064098A1Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effectFiled 2001·Application pending·0 cites
- 1144US2004058926A1Method of using cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disordersFiled 2001·Application pending·0 cites
- 1242US2002119193A1Oral fast-melt formulation of a cyclooxygenase-2 inhibitorFiled 2001·Application pending·0 cites
- 1337US2002071857A1Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitorFiled 2001·Application pending·0 cites
- 1437US2002128267A1Method of using COX-2 inhibitors in the treatment and prevention of ocular COX-2 mediated disordersFiled 2001·Application pending·0 cites
- 1537US2002107250A1Rapid-onset formulation of a selective cyclooxygenase-2 inhibitorFiled 2001·Application pending·0 cites
- 1637US2002049233A1Oral fast-melt dosage form of a cyclooxygenase-2 inhibitorFiled 2001·Application pending·0 cites
- 1736US2002035264A1Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drugFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →